Alcohol and tobacco use prediagnosis and postdiagnosis, and survival in a cohort of patients with early stage cancers of the oral cavity, pharynx, and larynx

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 12, 2009, Pages 3368-3374

  Mayne, Susan T ^a   Cartmel, Brenda ^a   Kirsh, Victoria ^a,b   Goodwin Jr , W Jarrard ^c  

^a YALE CANCER CENTER   (United States)

^b CANCER CARE ONTARIO   (Canada)

^c UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; PHARYNX CANCER; PRIORITY JOURNAL; SMOKING; SMOKING CESSATION;

AGED; ALCOHOL DRINKING; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; PHARYNGEAL NEOPLASMS; PLACEBOS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; SURVIVAL RATE;

EID: 73349109111     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-09-0944     Document Type: Article

References (21)

1. American Cancer Society. Cancer Facts and Figures 2008. Atlanta: American Cancer Society; 2008.
2. Do KA, Johnson MM, Doherty DA, et al. Second primary tumors in patients with upper aerodigestive tract cancers: joint effects of smoking and alcohol (United States). Cancer Causes Control 2003;14:131-8.
3. Winn DM, Blot WJ. Second cancer following cancers of the buccal cavity and pharynx in Connecticut, 1935-1982. J Natl Cancer Inst Monogr 1985;68:25-48.
4. Sturgis EM, Miller RH. Second primary malignancies in the head and neck cancer patient. Ann Otol Rhinol Laryngol 1995;104:946-54.
5. Cooper JS, Pajak TF, Rubin P, et al. Second malignancies in patients who have head and neck cancer: incidence, effect on survival and implications based on the RTOG experience. Int J Radiat Oncol Biol Phys 1989;17:449-56.
6. Khuri FF, Lee JJ, Lippman S, et al. Randomized phase III trial of lowdose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients. J Natl Cancer Inst 2006;98: 441-50.
7. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years' observations on male British doctors [see comment]. BMJ 1994;309:901-11.
8. Doll R, Peto R, Hall E, Wheatley K, Gray R. Mortality in relation to consumption of alcohol: 13 years' observations on male British doctors [see comment]. BMJ 1994;309:911-8.
9. Mayne ST, Cartmel B, Baum M, et al. Randomized trial of supplemental β-carotene to prevent second head and neck cancer. Cancer Res 2001;61:1457-63.
10. Hong WK, Lippman SM, Itri LM, et al. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med 1990;323:795-801.
11. Bolla M, Lefur R, Ton Van J, et al. Prevention of second primary tumors with etretinate in squamous cell carcinoma of the oral cavity and oropharynx. Results of a multicentric double-blind randomized study. Eur J Cancer 1994;30A:767-72.
12. van Zandwijk N, Dalesio O, Pastorino U, et al. For the European Organization for Research and Treatment of Cancer of the Head and Neck and Lung Cancer Cooperative Groups. EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. J Natl Cancer Inst 2000;92:977-86.
13. Bairati I, Meyer F, Jobin E, et al. Antioxidant vitamins supplementation and mortality: a randomized trial in head and neck cancer patients. Int J Cancer 2006;119:2221-4. 14. Toma S, Bonelli L, Sartoris A, et al. β-carotene supplementation in patients radically treated for stage I-II head and neck cancer: results of a randomized trial. Oncol Rep 2003;10:1895-901.
14. Deleyiannis FW-B, Thomas DB, Vaughan TL, Davis S. Alcoholism: independent predictor of survival in patients with head and neck cancer. J Natl Cancer Inst 1996;88:542-9.
15. Gritz ER, Carr CR, Rapkin D, et al. Predictors of long-term smoking cessation in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev 1993;2:261-70.
16. Day GL, Blot WJ, Shore RE, et al. Second cancers following oral and pharyngeal cancers: role of tobacco and alcohol. J Natl Cancer Inst 1994;86:131-7.
17. Mayne ST, Morse DE, Winn DM. Cancers of the oral cavity and pharynx. In: Schottenfeld D, Fraumeni JF, Jr., editors. Cancer Epidemiology and Prevention. 3rd ed. New York: Oxford University Press; 2006, p. 674-96.
18. Soleas GJ, Grass L, Josephy PD, Goldberg DM, Diamandis EP. A comparison of the anticarcinogenic properties of four red wine polyphenols. Clin Biochem 2002;35:119-24.
19. Gammon MD, Schoenberg JB, Ahsan H, et al. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia: results from a multi-center, case-control study. J Natl Cancer Inst 1997;89:1277-84.
20. Curado MP, Hashibe M. Recent changes in the epidemiology of head and neck cancer. Curr Opin Oncol 2009;21:194-200.
21. Hafkamp HC, Manni JJ, Haesevoets A, et al. Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer 2008;122:2656-64.